Relationship between amyloid β protein and melatonin metabolite in a study of electric utility workers

Journal of Occupational and Environmental Medicine

Volumn 44, Issue 8, 2002, Pages 769-775

  Noonan, Curtis W ^a   Reif, John S ^a   Burch, James B ^a   Ichinose, Travers Y ^a   Yost, Michael G ^a   Magnusson, Kathy ^a  

^a AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; AMYLOID BETA PROTEIN; ISOPROTEIN; MELATONIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CONCENTRATION RESPONSE; DISEASE ASSOCIATION; ELECTRIC INJURY; ELECTRICAL EQUIPMENT; HUMAN; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; METABOLITE; OBSERVATION; OCCUPATIONAL ACCIDENT; OCCUPATIONAL EXPOSURE; STATISTICAL SIGNIFICANCE; URINALYSIS; WORKER; BLOOD; ELECTROMAGNETIC FIELD; ENVIRONMENTAL MONITORING; MIDDLE AGED; URINE;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ELECTROMAGNETIC FIELDS; ENVIRONMENTAL MONITORING; HUMANS; MALE; MELATONIN; MIDDLE AGED; OCCUPATIONAL EXPOSURE;

EID: 0036667870     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-200208000-00012     Document Type: Article

References (47)

1. Genesis of Alzheimer's disease
2. Occupations with exposure to electromagnetic fields: A possible risk factor for Alzheimer's disease
3. Elevated risk of Alzheimer's disease among workers with likely exposure to electromagnetic field exposure
4. Electrical occupations and neurodegenerative disease: Analysis of U. S. mortality data
5. Magnetic field exposure and neurodegenerative disease mortality among electric utility workers
6. Neurodegenerative diseases: Occupational occurrence and potential risk factors
7. Dementia and occupational exposure to magnetic fields
8. Effects of exposure to 16.7 Hz magnetic fields on urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers
9. Chronic exposure to 2.9 mT, 40 Hz magnetic field reduces melatonin concentrations in humans
10. Nocturnal excretion of a urinary melatonin metabolite in electric utility workers
11. Reduced excretion of a melatonin metabolite in workers exposed to 60 Hz magnetic fields
12. Melatonin metabolite levels in workers exposed to 60 Hz magnetic fields: Work in substations and with 3-phase conductors
13. Melatonin alters the metabolism of the β-amyloid precursor protein in the neuroendocrine cell line PC12
14. Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types
15. The amyloid precursor protein of Alzheimer's disease is released by human platelets
16. Synthesis and secretion of Alzheimer amyloid βA4 precursor protein by stimulated human peripheral blood leucocytes
17. Stimulated release of the β-amyloid protein of Alzheimer's disease by normal human platelets
18. Detection of soluble forms of the β-amyloid precursor protein in human plasma
19. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
20. Amyloid β protein 42(3) in cerebrospinal fluid of patients with Alzheimer's disease
21. Increased plasma amyloid β protein 1-42 levels in Down's syndrome
22. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
23. Plasma levels of amyloid β proteins Aβ1-40 and Aβ1-42(3) are elevated in Down's Syndrome
24. The βAPP717 Alzheimer mutation increases the percentage of plasma amyloid-β protein ending at Aβ42(3)
25. Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome
26. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease
27. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: Abolition of the urinary 24-hour rhythm with atenolol
28. Variability and consistency of electric and magnetic field occupational exposure measurements
29. Occupational exposure to magnetic fields in case-referent studies of neurodegenerative diseases
30. Risk of cognitive impairment in relation to elevated exposure to electromagnetic fields
31. Exposure to electromagnetic fields and risk of central nervous system disease in utility workers
32. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: Effect of age and Alzheimer's disease
33. Chrono-neuroendrocrinological aspects of physiological aging and senile dementia
34. Melatonin: A potent, endogenous hydroxyl radical scavenger
35. Melatonin stimulates brain glutathione peroxidase activity
36. Oxidative stress increases production of β-amyloid precursor protein and β-amyloid (Aβ) in mammalian lenses, and Aβ has toxic effects on lens epithelial cells
37. Nonenzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide
38. 2-induced apoptosis in human neuronal cells
39. 2+]-dependent ATPase in cardiac sarcolemma
40. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner
41. Calcium ionophore increases amyloid β peptide production by cultured cells
42. 2+ channels provides a mechanism for neuronal death in Alzheimer's disease
43. β-amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease
44. Actions of neurotoxic β-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists
45. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide
46. A case-control study of Alzheimer's disease in Australia
47. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study